These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 28135786)
1. The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions. Janssen PW; Bergmeijer TO; Godschalk TC; Le TT; Breet NJ; Kelder JC; Hackeng CM; Ten Berg JM J Thromb Haemost; 2017 Apr; 15(4):618-623. PubMed ID: 28135786 [TBL] [Abstract][Full Text] [Related]
2. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study. Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493 [TBL] [Abstract][Full Text] [Related]
3. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention. Yao Y; Zhang JH; Tang XF; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Wang M; Gao RL; Yuan JQ Chin Med J (Engl); 2016 Oct; 129(19):2269-74. PubMed ID: 27647183 [TBL] [Abstract][Full Text] [Related]
4. A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention. Jang J; Lim J; Chang K; Kim Y; Kim M; Park HI; Kim J; Shin S J Clin Lab Anal; 2012 Jul; 26(4):262-6. PubMed ID: 22811359 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470 [TBL] [Abstract][Full Text] [Related]
7. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Luo Y; Li J; Liu X; Xu J; Ye Z; Yao Y; Liu X; Lai Y Thromb Res; 2016 Mar; 139():114-20. PubMed ID: 26916306 [TBL] [Abstract][Full Text] [Related]
8. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI. Angiolillo DJ; Franchi F; Waksman R; Sweeny JM; Raveendran G; Teng R; Zhao Y; Carlson G; Khan N; Mehran R J Am Coll Cardiol; 2016 Feb; 67(6):603-613. PubMed ID: 26868683 [TBL] [Abstract][Full Text] [Related]
9. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820 [TBL] [Abstract][Full Text] [Related]
10. Cigarette Smoking Does Not Enhance Clopidogrel Responsiveness After Adjusting VerifyNow P2Y12 Reaction Unit for the Influence of Hemoglobin Level. Kim YG; Suh JW; Kang SH; Park JJ; Yoon CH; Cho YS; Youn TJ; Chae IH; Choi DJ; Kim HS JACC Cardiovasc Interv; 2016 Aug; 9(16):1680-90. PubMed ID: 27539687 [TBL] [Abstract][Full Text] [Related]
11. Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study. Varenhorst C; Koul S; Erlinge D; Lagerqvist B; Siegbahn A; Wallentin L; James S Am Heart J; 2011 Aug; 162(2):363-71. PubMed ID: 21835299 [TBL] [Abstract][Full Text] [Related]
13. Predictive values of post-clopidogrel platelet reactivity assessed by different platelet function tests on ischemic events in East Asian patients treated with PCI. Zhang HZ; Kim MH; Jeong YH Platelets; 2014; 25(4):292-9. PubMed ID: 23971791 [TBL] [Abstract][Full Text] [Related]
14. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study. Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009 [TBL] [Abstract][Full Text] [Related]
15. Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel? Pendyala LK; Loh JP; Lhermusier T; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R Am Heart J; 2014 Oct; 168(4):545-51. PubMed ID: 25262265 [TBL] [Abstract][Full Text] [Related]
16. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669 [TBL] [Abstract][Full Text] [Related]
17. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738 [TBL] [Abstract][Full Text] [Related]
18. The effect of acenocoumarol on the antiplatelet effect of clopidogrel. Dewilde WJ; Janssen PW; Bergmeijer TO; Kelder JC; Hackeng CM; ten Berg JM Thromb Haemost; 2015 Oct; 114(4):708-16. PubMed ID: 26177793 [TBL] [Abstract][Full Text] [Related]
19. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
20. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]